Complete report is available @ http://www.rnrmarketresearch.com/partnerships-licensing-investments-and-ma-deals-and-trends-in-pharmaceuticals-q4-2013-market-report.html . <br /> <br />“Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on partnerships, licensing agreements, M&As, equity/debt offerings, private equity and venture financing transactions registered in the pharmaceutical and healthcare industry in Q4 2013. The report presents detailed comparative data on the number of deals and their value in the past five quarters subdivided into deal types, segments, and geographies. The report also offers information on the top venture capital and advisory firms in the pharmaceutical and healthcare industry. <br /> <br />Researcher derived the data presented in this report from proprietary in-house Pharma deals database and through primary and secondary research. <br /> <br />Deal Values Of M&A’s Increased In Q4 2013 <br /> <br />Merger and acquisition (M&A) deals, including asset purchases, recorded a decrease in the number of deals and an increase in deal values in Q4 2013 with 336 deals worth $41.8 billion, compared to 382 deals worth $18.9 billion in Q4 2012. On a quarter-on-quarter basis, the number of deals and their values decreased in Q4 2013, compared to 399 deals worth $55.4 billion in Q3 2013. <br /> <br />The central nervous system therapeutics markets recorded the highest number of deals in Q4 2013 and stood at the top in deal activity. The market recorded 37 deals worth $9 billion in Q4 2013.
